Attovia Therapeutics Inc.
ATTO | NASDAQ
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET
TTM Period Ending | TTM 2025 Dec 30, 2025 | TTM 2024 Dec 30, 2024 |
|---|---|---|
PE Ratio | -15.42 | -20.86 |
PEG Ratio | -0.44 | n/a |
PS Ratio | 698.03 | n/a |
PB Ratio | 6.25 | 15.17 |
P/FCF Ratio | -15.32 | -25.60 |
P/OCF Ratio | -15.92 | -26.90 |
OCF/S Ratio | -4.39K | n/a |
Debt / Equity Ratio | 0.03 | n/a |
Quick Ratio | 14.20 | 9.39 |
Current Ratio | 14.20 | 9.39 |
Asset Turnover | 0.01 | n/a |
Interest Coverage | n/a | n/a |
Return on Equity | -40.21% | -64.06% |
Return on Assets | -36.55% | -51.88% |
Return on Invested Capital | -42.83% | -60.23% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | 40.44% | n/a |
Net Profit Margin | -4.49K% | n/a |
Pretax Profit Margin | -4.49K% | n/a |
Operating Profit Margin | -4.97K% | n/a |
FCF Margin | -4.56K% | n/a |
EBITDA Margin | -4.92K% | n/a |
Add to Watchlist
Select watchlists to add or remove ATTO